437 related articles for article (PubMed ID: 25973559)
1. Evolution of Facial Aesthetic Treatment Over Five or More Years: A Retrospective Cross-sectional Analysis of Continuous OnabotulinumtoxinA Treatment.
Carruthers A; Sadick N; Brandt F; Trindade de Almeida AR; Fagien S; Goodman GJ; Raspaldo H; Smith K; Darmody S; Gallagher CJ; Street J; Romagnano L
Dermatol Surg; 2015 Jun; 41(6):693-701. PubMed ID: 25973559
[TBL] [Abstract][Full Text] [Related]
2. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines.
Carruthers J; Rivkin A; Donofrio L; Bertucci V; Somogyi C; Lei X; Davis PG; Campo A; Beddingfield FC
Dermatol Surg; 2015 Jun; 41(6):702-11. PubMed ID: 25993609
[TBL] [Abstract][Full Text] [Related]
3. Subject satisfaction with onabotulinumtoxinA treatment of glabellar and lateral canthal lines using a new patient-reported outcome measure.
Rivers JK; Bertucci V; McGillivray W; Muhn C; Rosen N; Solish N; Weichman BM; Wheeler S; Daniels SR; Gallagher CJ
Dermatol Surg; 2015 Aug; 41(8):950-9. PubMed ID: 26218728
[TBL] [Abstract][Full Text] [Related]
4. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
Beer KR; Julius H; Dunn M; Wilson F
J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
[TBL] [Abstract][Full Text] [Related]
5. The South American Glabellar Experience Study (SAGE): a multicenter retrospective analysis of real-world treatment patterns following the introduction of incobotulinumtoxinA in Argentina.
Banegas RA; Farache F; Rancati A; Chain M; Gallagher CJ; Chapman MA; Caulkins CA
Aesthet Surg J; 2013 Sep; 33(7):1039-45. PubMed ID: 23990584
[TBL] [Abstract][Full Text] [Related]
6. OnabotulinumtoxinA and Hyaluronic Acid in Facial Wrinkles and Folds: A Prospective, Open-Label Comparison.
Cohen JL; Swift A; Solish N; Fagien S; Glaser DA
Aesthet Surg J; 2019 Jan; 39(2):187-200. PubMed ID: 29762642
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, Patient-Reported Outcomes, and Safety in Male Subjects Treated With OnabotulinumtoxinA for Improvement of Moderate to Severe Horizontal Forehead Lines.
Keaney TC; Cavallini M; Leys C; Rossi A; Drinkwater A; Manson Brown S; Garcia JK; Mao C
Dermatol Surg; 2020 Feb; 46(2):229-239. PubMed ID: 31343446
[TBL] [Abstract][Full Text] [Related]
8. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
Lowe NJ; Shah A; Lowe PL; Patnaik R
J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
[TBL] [Abstract][Full Text] [Related]
9. OnabotulinumtoxinA for Treatment of Forehead and Glabellar Lines: Subject-Reported Satisfaction and Impact From a Phase 3 Double-Blind Study.
Ogilvie P; Rivkin AZ; Dayan S; Yoelin SG; Weichman BM; Garcia JK
Dermatol Surg; 2019 May; 45(5):689-699. PubMed ID: 31034447
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Approach to Multimodal Facial Aesthetic Treatment: Injection Techniques and Treatment Characteristics From the HARMONY Study.
Narurkar VA; Cohen JL; Dayan S; Kaminer MS; Rivkin A; Shamban A; Sykes JM; Teller CF; Weinkle SH; Werschler WP; Drinkwater A; Pucci ML; Gallagher CJ
Dermatol Surg; 2016 May; 42 Suppl 2():S177-91. PubMed ID: 27128246
[TBL] [Abstract][Full Text] [Related]
11. Safety, Efficacy, and Patient Satisfaction With OnabotulinumtoxinA for the Treatment of Upper Facial Lines in Japanese Subjects.
Kawashima M; Harii K; Horiuchi Y; Seidman E; Lei X; Hopfinger R; Lee E
Dermatol Surg; 2020 Apr; 46(4):483-490. PubMed ID: 31517663
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, Patient-Reported Outcomes, and Safety for Millennial Subjects Treated With OnabotulinumtoxinA for Moderate to Severe Horizontal Forehead Lines.
Palm MD; Few J; Patel T; Safa M; Drinkwater A; Mao C; Garcia JK
Dermatol Surg; 2020 May; 46(5):653-661. PubMed ID: 31625954
[TBL] [Abstract][Full Text] [Related]
13. Impact of Comprehensive, Minimally Invasive, Multimodal Aesthetic Treatment on Satisfaction With Facial Appearance: The HARMONY Study.
Weinkle SH; Werschler WP; Teller CF; Sykes JM; Shamban A; Rivkin A; Narurkar VA; Kaminer MS; Dayan S; Cohen JL; Gallagher CJ
Aesthet Surg J; 2018 Apr; 38(5):540-556. PubMed ID: 29244069
[TBL] [Abstract][Full Text] [Related]
14. Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines.
De Boulle K; Werschler WP; Gold MH; Bruce S; Sattler G; Ogilvie P; Street J; Larsen KE; Yushmanova I; Lei X; Lee E; Vitarella D; Mao C
Dermatol Surg; 2018 Nov; 44(11):1437-1448. PubMed ID: 30096106
[TBL] [Abstract][Full Text] [Related]
15. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.
Prager W; Rappl T
J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of OnabotulinumtoxinA Treatment of Forehead Lines: A Multicenter, Randomized, Dose-Ranging Controlled Trial.
Solish N; Rivers JK; Humphrey S; Muhn C; Somogyi C; Lei X; Bhogal M; Caulkins C
Dermatol Surg; 2016 Mar; 42(3):410-9. PubMed ID: 26863598
[TBL] [Abstract][Full Text] [Related]
17. Full-face treatment with onabotulinumtoxinA: Results from a single-center study.
D'Emilio R; Rosati G
J Cosmet Dermatol; 2020 Apr; 19(4):809-816. PubMed ID: 31486568
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
Dessy LA; Fallico N; Mazzocchi M; Scuderi N
Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
[TBL] [Abstract][Full Text] [Related]
19. Patient satisfaction and safety with aesthetic onabotulinumtoxinA after at least 5 years: a retrospective cross-sectional analysis of 4,402 glabellar treatments.
Trindade de Almeida A; Carruthers J; Cox SE; Goldman MP; Wheeler S; Gallagher CJ
Dermatol Surg; 2015 Jan; 41 Suppl 1():S19-28. PubMed ID: 25548841
[TBL] [Abstract][Full Text] [Related]
20. OnabotulinumtoxinA treatment of mild glabellar lines in repose.
Carruthers A; Carruthers J; Lei X; Pogoda JM; Eadie N; Brin MF
Dermatol Surg; 2010 Dec; 36 Suppl 4():2168-71. PubMed ID: 21134048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
